Medical Device Incident Response Plan: FDA Requirements

Master FDA medical device incident response plan requirements. Learn how to draft, test, and execute a compliant IRP to ensure patient safety and data security.

This guide is written for medical device manufacturers navigating medical device incident response plan FDA. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

The Critical Role of Incident Response in Medical Device Safety

The Critical Role of Incident Response in Medical Device Safety is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

FDA Expectations: Section 524B and Postmarket Guidelines

FDA Expectations: Section 524B and Postmarket Guidelines — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Defining a 'Medical Device Cybersecurity Incident' vs. IT Incident

Defining a 'Medical Device Cybersecurity Incident' vs. IT Incident — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Core Components of an FDA-Compliant Incident Response Plan (IRP)

Core Components of an FDA-Compliant Incident Response Plan (IRP) is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Preparation: Establishing Your MedTech IR Team

Preparation: Establishing Your MedTech IR Team — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Detection and Analysis: Identifying Device Vulnerabilities vs. Exploits

Detection and Analysis: Identifying Device Vulnerabilities vs. Exploits — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Containment, Eradication, and Recovery Strategies

Containment, Eradication, and Recovery Strategies — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Post-Incident Activity: Root Cause Analysis and CAPA Integration

Post-Incident Activity: Root Cause Analysis and CAPA Integration — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Mandatory Reporting: When and How to Notify the FDA

Mandatory Reporting: When and How to Notify the FDA is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Determining 'Uncontrolled Risk' and Patient Safety Impact

Determining 'Uncontrolled Risk' and Patient Safety Impact — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Reporting Timelines: 21 CFR Part 803 (MDR) Requirements

Reporting Timelines: 21 CFR Part 803 (MDR) Requirements — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Integrating Your IRP with Quality Management Systems (QMS)

Integrating Your IRP with Quality Management Systems (QMS) is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Alignment with ISO 13485 and 21 CFR Part 820

Alignment with ISO 13485 and 21 CFR Part 820 — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Coordinating with Product Security and Engineering Teams

Coordinating with Product Security and Engineering Teams — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Testing Your Plan: Medical Device IR Tabletop Exercises

Testing Your Plan: Medical Device IR Tabletop Exercises is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Frequently asked questions

### What are the FDA requirements for a medical device incident response plan?

Short answer: medical device incident response plan FDA is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How does an IRP differ for legacy medical devices vs. new submissions?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

When do I need to report a cybersecurity incident to the FDA?

Short answer: Treat cybersecurity as a parallel workstream from concept onward; teams that bolt it on at design freeze almost always slip their submission date. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What is the difference between a vulnerability and a cybersecurity incident in MedTech?

Short answer: medical device incident response plan FDA is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How often should medical device makers test their incident response plans?

Short answer: It depends on the device classification, intended use, and connectivity profile — but the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Where this fits in the cluster

This page sits downstream of our pillar resources on medical device incident response plan FDA. If you arrived here from a different starting point, these are the most useful adjacent pages:

• FDA Postmarket Cybersecurity Services
• The Postmarket Cybersecurity Readiness Plan
• FDA Cybersecurity Deficiency Response
• FDA Cybersecurity Deficiency Letter Response Checklist

Related from Blue Goat Cyber

• FDA Premarket Cybersecurity Services
• Medical Device Penetration Testing
• FDA-Compliant SBOM Services
• The SPDF Playbook for FDA-Ready Medical Devices
• Medical Device Threat Modeling

Sources & primary references

• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions — U.S. Food and Drug Administration (FDA)
• Postmarket Management of Cybersecurity in Medical Devices — U.S. Food and Drug Administration (FDA)
• Computer Security Incident Handling Guide (SP 800-61 Rev. 2) — NIST
• AAMI TIR57: Principles for medical device security—Risk management — AAMI

Talk to a regulatory cybersecurity team

If you are working through medical device incident response plan FDA and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.